iNO300 Therapy in Critically Ill Patients With Pneumonia

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

October 31, 2026

Conditions
Critical IllnessPneumonia
Interventions
DRUG

High dose inhaled nitric oxide

Inhaled nitric oxide starting at 250-300 ppm, 40min, every 6 hours, from day 1 to day 5

OTHER

Sham treatment

Sham treatment with nitric oxide delivering and monitoring devices connected as the intervention group

OTHER

standard therapy

Standard therapy pneumonia and critical illness

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER